EHA 2017: keeping in touch with the world
Optimism for the use of liquid biopsies in multiple myeloma
Andrew Spencer et al.
The rationale behind the Myeloma UK Clinical Trial Network
The use of immunophenotyping to assess minimal residual disease (MRD) in multiple myeloma
An E-learning tool for hematology-oncology nurses